Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012) : an open-label randomised trial

• GORE ME

収録刊行物

• Lancet

  Lancet 375 641-648, 2010

詳細情報

• CRID: 1571417125775015680
• NII論文ID: 10030720400
• データソース種別:
  • CiNii Articles